Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Isotretinoin vs Topical Tretinoin for Actinic Keratosis Prevention
NCT02278861Phase 2Completed
- Sponsor
- Universidade Federal de Goiás
- Start
- Nov 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of isotretinoin in actinic keratosis (AK), sponsored by Universidade Federal de Goiás. Primary endpoint: Reduction in the counting of actinic keratosis at 10 months. Started Nov 2011; status: completed.
02
Drugs
isotretinoin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02278861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278861.